🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
BACKGROUND AND RATIONALE. The role of type I interferons (IFN) in innate an...
Status
Recruiting
Location
University of Pisa
Start Date
2023-05-25
Trial ID
NCT07215754
The purpose of this study is to evaluate the long-term safety of anifroluma...
Status
Completed
Location
Research Site
Start Date
2013-03-28
Trial ID
NCT01753193
Treatments Being Tested
This study will be conducted to characterize pharmacokinetics, pharmacodyna...
Status
Completed
Location
Research Site
Start Date
2017-02-14
Trial ID
NCT02962960
Treatments Being Tested
The purpose of this study is to assess safety, tolerability, pharmacokineti...
Status
Completed
Location
Research Site
Start Date
2012-04-20
Trial ID
NCT01559090
Systemic Lupus Erythematosus (SLE) is a multi-system autoimmune disorder, c...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-03-17
Trial ID
NCT06784076
Treatments Being Tested
The ANISE-II study is a randomized, double-blind, placebo-controlled phase ...
Status
Unknown
Location
University Medical Centre Groningen
Start Date
2022-10-01
Trial ID
NCT05383677
Treatments Being Tested
This clinical trial aims to study if a drug called anifrolumab works to tre...
Status
Completed
Location
UNC Dermatology and Skin Cancer Center
Start Date
2024-06-21
Trial ID
NCT06374212
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of MEDI-54...
Status
Completed
Location
Research Site
Start Date
2012-01
Trial ID
NCT01438489
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of an intr...
Status
Completed
Location
Research Site
Start Date
2015-06-09
Trial ID
NCT02446912
Treatments Being Tested
The purpose of this study is to characterise long-term safety and tolerabil...
Status
Completed
Location
Research Site
Start Date
2016-06-30
Trial ID
NCT02794285
Treatments Being Tested